These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6903992)
41. Chemotherapy: thoughts and images of patients with cancer. Manson H; Manderino MA; Johnson MH Oncol Nurs Forum; 1993 Apr; 20(3):527-31; discussion 531-2. PubMed ID: 8497420 [TBL] [Abstract][Full Text] [Related]
42. Nursing the clinic vs. nursing the patient: nurses' experience of a day hospital chemotherapy service. Mcilfatrick S; Sullivan K; McKenna H J Clin Nurs; 2006 Sep; 15(9):1170-8. PubMed ID: 16911058 [TBL] [Abstract][Full Text] [Related]
43. Targeted cancer. These "smart weapons" hit cancer in novel ways. Held-Warmkessel J Nursing; 2008 Sep; 38(9):26-32. PubMed ID: 18719487 [TBL] [Abstract][Full Text] [Related]
44. Background noise: the experience of chemotherapy-induced peripheral neuropathy. Bakitas MA Nurs Res; 2007; 56(5):323-31. PubMed ID: 17846553 [TBL] [Abstract][Full Text] [Related]
45. Application of ambulatory infusion devices in infusional cancer chemotherapy: a model for nursing management. Moore C; Herbst S; Lawson M J Infus Chemother; 1996; 6(4):181-5. PubMed ID: 9229313 [TBL] [Abstract][Full Text] [Related]
46. Manage cardiac side effects of cancer treatment. Becze E ONS Connect; 2008 Dec; 23(12):18-9. PubMed ID: 19093341 [No Abstract] [Full Text] [Related]
47. Benefits of using a chemotherapy symptom assessment scale. Dikken C Nurs Times; 2003 Sep 30-Oct 6; 99(39):50-1. PubMed ID: 14562665 [TBL] [Abstract][Full Text] [Related]
48. Older adults' functional performance loss and adaptation during chemotherapy. Goodwin JA Geriatr Nurs; 2007; 28(6):370-6. PubMed ID: 18068820 [TBL] [Abstract][Full Text] [Related]
49. Chemotherapy-induced neurotoxicity: assessment and interventions for patients at risk. Nielsen E; Brant J Am J Nurs; 2002 Apr; 102 Suppl 4():16-9; quiz 49-52. PubMed ID: 11953532 [No Abstract] [Full Text] [Related]
50. Nurses' guide to understanding and implementing the National Comprehensive Cancer Network guidelines for myeloid growth factors. Wilson BJ; Gardner AE Oncol Nurs Forum; 2007 Mar; 34(2):347-53. PubMed ID: 17573299 [TBL] [Abstract][Full Text] [Related]
51. Cellular effects of cancer chemotherapy administration. Moran P J Intraven Nurs; 2000; 23(1):44-51. PubMed ID: 11013533 [TBL] [Abstract][Full Text] [Related]
52. Teeth. Mouth care in cancer. Porter H Nurs Times; 1994 Apr 6-12; 90(14):27-9. PubMed ID: 8183688 [No Abstract] [Full Text] [Related]
56. [Nutrition control of cancer patients under chemotherapy]. Satoh S Kango; 1994 May; 46(5):199-212. PubMed ID: 7807856 [No Abstract] [Full Text] [Related]
57. [Limits and value of chemotherapy in elderly patients]. Engert A; Schnell R; Lathan B; Diehl V Med Klin (Munich); 1994 Nov; 89(11):603-10. PubMed ID: 7815990 [No Abstract] [Full Text] [Related]
58. Surveillance of the patient receiving infusional cancer chemotherapy: nursing role in recognition and management of catheter-related complications. The Cancer Center of Boston. Moore C; Strong D; Childress J; Fougere B; Gotthardt S J Infus Chemother; 1996; 6(4):171-80. PubMed ID: 9229312 [TBL] [Abstract][Full Text] [Related]
59. Effect of a cognitive behavioral intervention on reducing symptom severity during chemotherapy. Given C; Given B; Rahbar M; Jeon S; McCorkle R; Cimprich B; Galecki A; Kozachik S; Brady A; Fisher-Malloy MJ; Courtney K; Bowie E J Clin Oncol; 2004 Feb; 22(3):507-16. PubMed ID: 14752074 [TBL] [Abstract][Full Text] [Related]
60. [Nursing for the prevention of infection in patients during cancer chemotherapy]. Hamagami S; Kashiwagi N; Furukawa K; Tsujihara T; Fujita E Kango Gijutsu; 1987 Sep; 33(12):1407-11. PubMed ID: 3682361 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]